Research Articles
Plasmid DNA is Protected against Ultrasonic Cavitation-Induced Damage when Complexed to Cationic Liposomes

https://doi.org/10.1021/js9504752Get rights and content

Abstract

Cationic liposomes bound to plasmid DNA are currently used for in vitro and in vivo gene therapy applications, but such complexes readily form large, heterogeneous aggregates that are not appropriate for pharmaceutical development. More importantly, size heterogeneity makes studies focused on optimizing gene transfer to cells difficult to conduct or understand. For this reason we have evaluated the effect of microprobe sonication on these complexes in an effort to acheive process-controlled size homogeneity. Complexes were prepared using a 7.2 kb reporter plasmid and the following liposomal lipid combinations: DDAB/DOPE (50:50 mol%), DDAB/DOPE/PEG-PE (50:45:5 mol%), DDAB/EPC (50:50 mol%), DDAB/EPC/PEG-PE (50:45:5, 50:40:10, 50:35:15 mol%), DODAC/DOPE (50:50 mol%), and DODAC/EPC (50:50 mol%) (DDAB, dimethyldioctadecylammonium bromide; DOPE, dioleoylphos-phatidylethanolamine; PEG-PE, monomethoxypolyethylene glycol2000 succinate–distearoylphosphatidylethanolamine; EPC, egg phosphatidylcholine; DODAC, dioleoyldimethylammonium chloride). The influence of complex composition and lipid:DNA ratio was evaluated. Particle size was determined before and after complexation and again after sonication using the quasi-elastic light scattering technique. DNA integrity was assessed via agarose gel electrophoresis. Finally, gene transfection was evaluated using CHO cells that were transfected in vitro with sonicated and unsonicated complexes. It is established in this study that size reduction can occur, but this is dependent on cationic and neutral lipid composition and, in some cases, lipid:DNA ratio. Surprisingly, the process of sonication leaves a significant percentage of the plasmid DNA intact and capable of in vitro transfection. This study shows that plasmid DNA can be protected from damage due to sonication by liposome complex formation. This may indicate that more common pharmaceutical methods for size reduction which subject particles to mechanical stress may be applicable in preparation of liposome/DNA formulations for in vivo application.

References and Notes (59)

  • F.L. Graham et al.

    Virology

    (1973)
  • P. Hug et al.

    Biochim. Biophys. Acta

    (1991)
  • A.M. Tari et al.

    Blood

    (1994)
  • X. Gao et al.

    Biochem. Biophys. Res. Commun.

    (1991)
  • H. Farhood et al.

    Biochim. Biophys. Acta

    (1992)
  • R. Philip et al.

    Biol. Chem.

    (1993)
  • H. Hofland et al.

    Biochem. Biophys. Res. Commun.

    (1995)
  • F.O. Nestle et al.

    J. Invest. Dermatol.

    (1994)
  • B. Sternberg et al.

    FEBS Lett.

    (1994)
  • C.P. Tilcock

    Chem. Phys. Lipids

    (1986)
  • J.H. Felgner et al.

    J. Biol. Chem.

    (1994)
  • M.J. Hope et al.

    Biochim. Biophys. Acta

    (1985)
  • J. Senior et al.

    Biochim. Biophys. Acta

    (1985)
  • I.A. Bakker-Woudenberg et al.

    Biochim. Biophys. Acta

    (1992)
  • D.C. Litzinger et al.

    Biochim. Biophys. Acta

    (1992)
  • D.P. Siegel

    Biophys. J.

    (1986)
  • J. Senior et al.

    Biochim. Biophys. Acta

    (1991)
  • J.J. Wheeler et al.

    J. Pharm. Sci.

    (1994)
  • A. Memoli et al.

    Int. J. Pharm.

    (1995)
  • H.B. Arnardottir et al.

    Int. J. Pharm.

    (1995)
  • T. Lepoint et al.

    Ultrason. Sonochem.

    (1994)
  • M.M. Chivate et al.

    Ultrason. Sonochem.

    (1995)
  • D.L. Miller et al.

    Ultrasound Med. Biol.

    (1991)
  • D.L. Miller et al.

    Ultrasound Med. Biol.

    (1991)
  • E. Mayhew et al.

    Biochim. Biophys. Acta

    (1984)
  • S. Zheng et al.

    Biochim. Biophys. Acta

    (1994)
  • P.R. Cullis et al.

    Chem. Phys. Lipids

    (1986)
  • S.A. Afione et al.

    Clin. Pharmacokinet.

    (1995)
  • F. Toneguzzo et al.

    Mol. Cell. Biol.

    (1986)
  • Cited by (74)

    • Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery

      2008, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      As the gaseous cavitation bubbles collapse, it causes the liquid to become intensely agitated, resulting in breaks in the double-stranded DNA.35,53 At the same time, chemically reactive species such as H2O2 and free radicals are produced, which can also harm the sonicated material.53 Sonication using a probe can result in the most harmful effects.46

    • DNA acts as a nucleation site for transient cavitation in the ultrasonic nebulizer

      2006, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      Only a few studies have been performed on the effects of ultrasonic nebulization on DNA for pulmonary delivery. Most of these investigations have focused on protecting DNA from cavitation and mechanical shear forces by complexing the DNA with cationic agents.7,8,35–37 However, the possibility that DNA can act as a heterogeneous nucleation site for cavitation has yet to be explored.

    View all citing articles on Scopus
    View full text